Coffee, caffeine, and cardiovascular health: navigating risks and benefits-an updated systematic review and meta-analysis
Shaban EE, Elmelliti H, Shaban A, Shaban A, Elkandow A, Abdelrahim MG, Zaki HA
BMC cardiovascular disorders · 0 citations
How it was studied
- Design
- Meta-analysis (indexed by PubMed)
- Studied in
- People
- Main outcome
- Clinical events such as disease or death
Who paid for it
- Funding
- Independent funding
Based on full-text disclosure statement.
Publication
- Published
- 2026-05-07 · BMC Cardiovasc Disord · vol. 26 · issue 1
- Publisher
- BioMed Central
- Cited
- 1 citation · more than 90% of similar papers · 3.0× the field average
- References
- 79 works
- Access
- Open access (journal) · CC-BY-NC-ND
- Research areas
- Coffee research and impacts · Alcohol Consumption and Health Effects · Tea Polyphenols and Effects
- Keywords
- Hazard ratio, Myocardial infarction, Stroke (engine), Odds ratio, Angiology, Caffeine, Cohort study, Epidemiology
- MeSH
- humans, cardiovascular diseases, caffeine, prognosis, risk assessment, risk factors, coffee, adult, aged, aged, 80 and over, middle aged, female, male, protective factors, heart disease risk factors
7 authors
From QA, EG
- Eman E. Shaban
- Hussam Elmelliti · correspondingHamad Medical Corporation
- Ahmed ShabanMansoura University Hospital
- Amira ShabanMansoura University Hospital
- Ali ElkandowHamad Medical Corporation
- Mohamed Gafar AbdelrahimHamad Medical Corporation
Abstract
Background
The association between coffee or caffeine intake and cardiovascular diseases (CVDs) and their risk factors has been extensively researched. However, there has been conflicting evidence. Therefore, the current updated meta-analysis assessed the relationship between coffee or caffeine with CVDs, such as coronary heart diseases (CHDs), myocardial infarction (MI), heart failure (HF), stroke, cardiac arrhythmias, and CVD mortality.
Methods
Five electronic databases, namely PubMed, Web of Science, Cochrane Library, Embase, and Scopus, were extensively searched for all records published between January 2000 and December 2025. Studies were included if they examined the effects of coffee on any CVD and reported the associations in terms of the hazard ratio (HR), relative risk (RR), or odds ratio (OR). Moreover, quality appraisal was conducted using the Newcastle Ottawa Scale for cohort studies and the Joanna Briggs Institute tool for case-control studies.
Results
After exclusions, 38 studies involving 2,856,002 participants were reviewed and analyzed. The pooled analysis showed no significant associations between coffee consumption and total CHDs or HF, when comparing the highest and lowest coffee consumption categories (HR: 0.98; p = 0.80 and HR: 1.03; p = 0.62, respectively). In contrast, the pooled results showed a significant positive association between higher coffee consumption and the risk of developing MI (OR: 1.48; p < 0.0001). The pooled analysis also showed an inverse relationship between coffee consumption and stroke or cardiac arrhythmias (HR: 0.89; p = 0.01 and HR: 0.94; p = 0.04, respectively). Furthermore, we observed a non-linear relationship between caffeine intake and CVD mortality among hypertensive patients (HR: 0.68; p = 0.001).
Conclusion
Higher coffee intake might increase the risk of MI, but can also offer protective effects against stroke and cardiac arrhythmias. Moreover, higher caffeine intake can reduce the risk of CVD mortality in hypertensive patients.
Clinical trial registration
PROSPERO: CRD420251073620.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY-NC-ND).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.